Eileen Lingshu Rose

Title: Eileen Lingshu Rose: Innovator in Antibody Development

Introduction

Eileen Lingshu Rose is a prominent inventor based in South San Francisco, CA. She has made significant contributions to the field of biotechnology, particularly in the development of antibodies that target specific proteins involved in immune responses.

Latest Patents

Eileen holds a patent for "SIRP α, SIRP β 1, and SIRP γ antibodies and uses thereof." This patent includes antibodies that bind to signal regulatory protein gamma (SIRPγ), as well as SIRPα and/or SIRPβ1. The SIRP antibodies are designed to be human monoclonal antibodies that can effectively bind human SIRPγ, SIRPα, and SIRPβ1. These antibodies are particularly useful for treating diseases associated with the overactivation and hyperproliferation of lymphocytes and myeloid cells.

Career Highlights

Eileen is currently associated with Electra Therapeutics, Inc., where she continues to advance her research and development efforts in antibody technology. Her work has the potential to impact various therapeutic areas, particularly those related to immune system disorders.

Collaborations

Eileen collaborates with notable colleagues, including Sandip Panicker and Adam David Rosenthal, who contribute to her innovative projects and research initiatives.

Conclusion

Eileen Lingshu Rose is a trailblazer in the field of antibody development, with a focus on SIRP antibodies that hold promise for treating immune-related conditions. Her contributions to biotechnology are noteworthy and continue to influence the industry.